Specific Depletion of Human Anti-adenovirus Antibodies Facilitates Transduction in an in Vivo Model for Systemic Gene Therapy

This publication has 35 references indexed in Scilit:

• Pre-Existent Adenovirus Antibody Inhibits Systemic Toxicity and Antitumor Activity of CN706 in the Nude Mouse LNCaP Xenograft Model: Implications and Proposals for Human Therapy
  Human Gene Therapy, 2000
• Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver
  Gene Therapy, 1999
• Cytotoxic T Lymphocyte Responses to Proteins Encoded by Heterologous Transgenes TransferredIn Vivoby Adenoviral Vectors
  Human Gene Therapy, 1997
• Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway
  Gene Therapy, 1997
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression
  Gene Therapy, 1997
• IMMUNOLOGIC BARRIERS TO HEPATIC ADENOVIRAL GENE THERAPY FOR TRANSPLANTATION
  Transplantation, 1997
• FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene Transfer
  Human Gene Therapy, 1995
• Adenovirus–mediated in vivo gene transfer and expression in normal rat liver
  Nature Genetics, 1992
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
  Cell, 1992
• The murine cellular immune response to adenovirus type 5
  Immunology & Cell Biology, 1989